- Analysis of the Effects of Group Progressive Resistance Training on Interleukin-8 (IL-8), Interleukin-18 (IL-18), Interleukin-6 (IL-6), Interleukin-12 (IL-12) and VO2max, VEmax, O2pulsemax, HRmax, and mMRC in Elderly Patients with Chronic Obstructive Pulm
Resistance Training on Interleukin-8 (IL-8), Interleukin-18 (IL-18), Interleukin-6 (IL-6), Interleukin-12 (IL-12)
Keywords:
Group progressive resistance training; Old age; Chronic obstructive pulmonary disease; Inflammatory factors and cardiopulmonary function, Interleukin-8 (IL-8), Interleukin-18 (IL-18), Interleukin-6 (IL-6),
Abstract
Objective To investigate the effects of implementing group progressive resistance training on Maximal Oxygen consumption (VO2max), Maximum Ventilation per minute (VEmax), Maximeal Oxygen pulse (O2pulsemax), Maximum Heart Rate (HRmax), and Modified Medical Research Councildyspneascale (mMRC) in elderly patients with chronic obstructive pulmonary disease. Method: 114 elderly patients with chronic obstructive pulmonary disease treated in the hospital from May 2022 to May 2024 were collected and divided into two groups based on different training methods. The conventional group (n=57) received routine rehabilitation training, while the organization group (n=57) received group progressive resistance training. To compare the improvement of training compliance, Cardiopulmonary Exercise Testing (CPET) parameters, serum inflammatory factors, lung function indicators, and mMRC score between two groups before training, 2 weeks of training, and 4 weeks of training. Results: Before training, there was no statistically significant difference (P>0.05) between the two groups in terms of Training Compliance Score (TCS), CPET parameter indicators, serum inflammatory factors, and mMRC score. After 2 weeks and 4 weeks of training, both groups of patients showed an increase in reported scores on training frequency, training intensity, autonomous training, and self training. The levels of VO2max, VEmax, O2pulsemax, and HRmax in both groups increased. In the comparison of these two groups of indicators, organization was higher than conventional group, and the difference was statistically significant (P<0.05). The levels of Interleukin-8 (IL-8), Interleukin-18 (IL-18), Interleukin-6 (IL-6), and Interleukin-12 (IL-12) decreased in both groups, and the mMRC scores of both groups decreased. The comparison between the two results showed that the organization was lower than conventional, and the difference was statistically significant (P<0.05). Conclusion: Group progressive resistance training can help improve the compliance of elderly patients with chronic obstructive pulmonary disease with training, reduce the body's inflammatory response, improve VO2max, VEmax, O2pulsemax, HRmax levels, and alleviate breathing difficulties.
References
Antoniu, S.A,Handra, C.M,Rascu, A.,Barbu, B.A, & Chirap Mitulschi, I. (2023). Navafenterol for chronic obstructive pulmonary disease therapy[J]. Expert opinion on investigational drugs, 32(4), 283-290. https://doi.org/10.1080/13543784.
Booth, S.,Hsieh, A.,Mostaco-Guidolin, L.,Koo, H.K,Wu, K.,Aminazadeh, F.,Yang, C.X,Quail, D.,Wei, Y.,Cooper, J.D,Paré, P.D,Hogg, J.C,Vasilescu, D.M, & Hackett, T.L (2023). A Single-Cell Atlas of Small Airway Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study[J]. American journal of respiratory and critical care medicine, 208(4), 472-486. https://doi.org/10.1164/rccm.
Bos, S.,Beeckmans, H.,Vanstapel, A.,Sacreas, A.,Geudens, V.,Willems, L.,Schreurs, I.,Vanaudenaerde, B.M,Schoemans, H., & Vos, R. (2022). Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin?. The Lancet[J]. Respiratory medicine, 10(8), 796-810. https://doi.org/10.1016/S2213-2600(22)00001-7
Cabrera López, C.,Sánchez Santos, A.,Lemes Castellano, A.,Cazorla Rivero, S.,Breña Atienza, J.,González Dávila, E.,Celli, B., & Casanova Macario, C. (2023). Eosinophil Subtypes in Adults with Asthma and Adults with Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 208(2), 155-162. https://doi.org/10.1164/rccm.
Cabrera López, C.,Sánchez Santos, A.,Lemes Castellano, A.,Cazorla Rivero, S.,Breña Atienza, J.,González Dávila, E.,Celli, B., & Casanova Macario, C. (2023). Eosinophil Subtypes in Adults with Asthma and Adults with Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine, 208(2), 155-162. https://doi.org/10.1164/rccm.
Christenson, S.A,Smith, B.M,Bafadhel, M., & Putcha, N. (2022). Chronic obstructive pulmonary disease[J]. Lancet (London, England), 399(10342), 2227-2242. https://doi.org/10.1016/S0140-6736(22)00470-6
Diaz, A.A,Orejas, J.L,Grumley, S.,Nath, H.P,Wang, W.,Dolliver, W.R,Yen, A.,Kligerman, S.J,Jacobs, K.,Manapragada, P.P,Abozeed, M.,Aziz, M.U,Zahid, M.,Ahmed, A.N,Terry, N.L,San José Estépar, R.,Kim, V.,Make, B.J,Han, M.K,Sonavane, S.,Washko, G.R,Cho, M., & San José Estépar, R. (2023). Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease[J]. JAMA, 329(21), 1832-1839. https://doi.org/10.1001/jama.
Duckworth, A.,Gibbons, M.A,Allen, R.J,Almond, H.,Beaumont, R.N,Wood, A.R,Lunnon, K.,Lindsay, M.A,Wain, L.V,Tyrrell, J., & Scotton, C.J (2021). Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study. The Lancet[J]. Respiratory medicine, 9(3), 285-294. https://doi.org/10.1016/S2213-2600(20)30364-7
Ekström, M.,Ferreira, D.,Chang, S.,Louw, S.,Johnson, M.J,Eckert, D.J,Fazekas, B.,Clark, K.J,Agar, M.R,Currow, D.C, & , . (2022). Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial[J]. JAMA, 328(20), 2022-2032. https://doi.org/10.1001/jama.2022.20206
Fahy, J.V, & Locksley, R.M (2023). Immune treatment tackles chronic obstructive pulmonary disease[J]. Nature, 621(7979), 476-477. https://doi.org/10.1038/d41586-023-02517-5
Fawzy, A.,Baker, J.R,Keller, T.L,Feemster, L.C,Donnelly, L.E, & Hansel, N.N (2022). Selected Bibliography of Recent Research in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(11), 1408-1417. https://doi.org/10.1164/rccm.
Feldman, W.B,Avorn, J.,Kesselheim, A.S, & Gagne, J.J (2023). Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers[J]. JAMA internal medicine, 183(7), 685-695. https://doi.org/10.1001/jamainternmed.
Florman, K.EH,Siddharthan, T.,Pollard, S.L,Alupo, P.,Barber, J.A,Chandyo, R.K,Flores-Flores, O.,Kirenga, B.,Mendes, R.G,Miranda, J.J,Mohan, S.,Ricciardi, F.,Rykiel, N.A,Sharma, A.K,Wosu, A.C,Checkley, W.,Hurst, J.R, & , . (2023). Unmet Diagnostic and Therapeutic Opportunities for Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Countries[J]. American journal of respiratory and critical care medicine, 208(4), 442-450. https://doi.org/10.1164/rccm.
Gai, X.,Allwood, B., & Sun, Y. (2023). Post-tuberculosis lung disease and chronic obstructive pulmonary disease[J]. Chinese medical journal, 136(16), 1923-1928. https://doi.org/10.1097/CM9.
Hernández Cordero, A.I,Yang, C.X,Yang, J.,Horvath, S.,Shaipanich, T.,MacIsaac, J.,Lin, D.TS,Kobor, M.S,Guillemi, S.,Harris, M.,Lam, W.,Lam, S.,Montaner, J.,Man, S.FP,Sin, D.D, & Leung, J.M (2022). Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(2), 150-160. https://doi.org/10.1164/rccm.
Kakkera, K.,Atchley, W.T,Kodali, M., & Bartter, T. (2023). Ageing and chronic obstructive pulmonary disease: interrelationships[J]. Current opinion in pulmonary medicine, 29(2), 90-95. https://doi.org/10.1097/MCP.
Kaul, M.,Krow, S.,Tan, A.M, & Singla, S. (2022). Phenotypic Heterogeneity in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 205(1), 118-120. https://doi.org/10.1164/rccm.
Lacasse, Y.,Casaburi, R.,Sliwinski, P.,Chaouat, A.,Fletcher, E.,Haidl, P., & Maltais, F. (2022). Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis[J]. The Lancet. Respiratory medicine, 10(11), 1029-1037. https://doi.org/10.1016/S2213-2600(22)00179-5
Long, H.,Li, S., & Chen, Y. (2023). Digital health in chronic obstructive pulmonary disease[J]. Chronic diseases and translational medicine, 9(2), 90-103. https://doi.org/10.1002/cdt3.68
Madapoosi, S.S,Cruickshank-Quinn, C.,Opron, K.,Erb-Downward, J.R,Begley, L.A,Li, G.,Barjaktarevic, I.,Barr, R.G,Comellas, A.P,Couper, D.J,Cooper, C.B,Freeman, C.M,Han, M.K,Kaner, R.J,Labaki, W.,Martinez, F.J,Ortega, V.E,Peters, S.P,Paine, R.,Woodruff, P.,Curtis, J.L,Huffnagle, G.B,Stringer, K.A,Bowler, R.P,Esther, C.R,Reisdorph, N.,Huang, Y.J, & , . (2022). Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(4), 427-439. https://doi.org/10.1164/rccm.
Malla, G.,Bodduluri, S.,Sthanam, V.,Sharma, G., & Bhatt, S.P (2023). Access to Pulmonary Rehabilitation among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease[J]. Annals of the American Thoracic Society, 20(4), 516-522. https://doi.org/10.1513/AnnalsATS.
Mangione, C.M,Barry, M.J,Nicholson, W.K,Cabana, M.,Caughey, A.B,Chelmow, D.,Coker, T.R,Davis, E.M,Donahue, K.E,Jaén, C.R,Kubik, M.,Li, L.,Ogedegbe, G.,Pbert, L.,Ruiz, J.M,Stevermer, J.,Tseng, C.W, & Wong, J.B (2022). Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement[J]. JAMA, 327(18), 1806-1811. https://doi.org/10.1001/jama.
Moll, M.,Boueiz, A.,Ghosh, A.J,Saferali, A.,Lee, S.,Xu, Z.,Yun, J.H,Hobbs, B.D,Hersh, C.P,Sin, D.D,Tal-Singer, R.,Silverman, E.K,Cho, M.H,Castaldi, P.J, & , . (2022). Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 205(2), 161-170. https://doi.org/10.1164/rccm.
Motahari, A.,Barr, R.G,Han, M.K,Anderson, W.H,Barjaktarevic, I.,Bleecker, E.R,Comellas, A.P,Cooper, C.B,Couper, D.J,Hansel, N.N,Kanner, R.E,Kazerooni, E.A,Lynch, D.A,Martinez, F.J,Newell, J.D,Schroeder, J.D,Smith, B.M,Woodruff, P.G,Hoffman, E.A, & , . (2023). Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 208(6), 67-665. https://doi.org/10.1164/rccm.
Mullin, M.LL, & Milne, S. (2023). Vitamin D deficiency in chronic obstructive pulmonary disease[J]. Current opinion in pulmonary medicine, 29(2), 96-103. ttps://doi.org/10.1097/MCP.0000000000000935
Nam, J.G,Kang, H.R,Lee, S.M,Kim, H.,Rhee, C.,Goo, J.M,Oh, Y.M,Lee, C.H, & Park, C.M (2022). Deep Learning Prediction of Survival in Patients with Chronic Obstructive Pulmonary Disease Using Chest Radiographs[J]. Radiology, 305(1), 199-208. ttps://doi.org/10.1148/radiol.
Otu, A.,Kosmidis, C.,Mathioudakis, A.G,Ibe, C., & Denning, D.W (2023). The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease[J]. Infection, 51(4), 813-829. ttps://doi.org/10.1007/s15010-022-01960-2
Qian, F.,van den Boom, W., & See, K.C (2023). Real-world evidence challenges controlled hypoxemia guidelines for critically ill patients with chronic obstructive pulmonary disease[J]. Intensive care medicine, 49(9), 1133-1135. ttps://doi.org/10.1007/s00134-023-07166-w.
Rabe, K.F,Rennard, S.,Martinez, F.J,Celli, B.R,Singh, D.,Papi, A.,Bafadhel, M.,Heble, J.,Radwan, A.,Soler, X.,Jacob Nara, J.A,Deniz, Y., & Rowe, P.J (2023). Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook[J]. American journal of respiratory and critical care medicine, 208(4), 395-405. https://doi.org/10.1164/rccm.
Raju, S.,Woo, H.,Koehler, K.,Fawzy, A.,Liu, C.,Putcha, N.,Balasubramanian, A.,Peng, R.D,Lin, C.T,Lemoine, C.,Wineke, J.,Berger, R.D,Hansel, N.N, & McCormack, M.C (2023). Indoor Air Pollution and Impaired Cardiac Autonomic Function in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 207(6), 721-730. https://doi.org/10.1164/rccm.
Ritchie, A.I,Baker, J.R,Parekh, T.M,Allinson, J.P,Bhatt, S.P,Donnelly, L.E, & Donaldson, G.C (2021). Update in Chronic Obstructive Pulmonary Disease 2020[J]. American journal of respiratory and critical care medicine, 204(1), 14-22. https://doi.org/10.1164/rccm.
Rojas, J.C,Chokkara, S.,Zhu, M.,Lindenauer, P.K, & Press, V.G (2023). Care Quality for Patients with Chronic Obstructive Pulmonary Disease in the Readmission Penalty Era[J]. American journal of respiratory and critical care medicine, 207(1), 29-37. https://doi.org/10.1164/rccm.
Rustam, S.,Hu, Y.,Mahjour, S.B,Rendeiro, A.F,Ravichandran, H.,Urso, A.,D'Ovidio, F.,Martinez, F.J,Altorki, N.K,Richmond, B.,Polosukhin, V.,Kropski, J.A,Blackwell, T.S,Randell, S.H,Elemento, O., & Shaykhiev, R. (2023). A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 207(9), 1171-1182. https://doi.org/10.1164/rccm.
Rustam, S.,Hu, Y.,Mahjour, S.B,Rendeiro, A.F,Ravichandran, H.,Urso, A.,D'Ovidio, F.,Martinez, F.J,Altorki, N.K,Richmond, B.,Polosukhin, V.,Kropski, J.A,Blackwell, T.S,Randell, S.H,Elemento, O., & Shaykhiev, R. (2023). A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 207(9), 1171-1182. https://doi.org/10.1164/rccm.
Ryu, M.H,Yun, J.H,Morrow, J.D,Saferali, A.,Castaldi, P.,Chase, R.,Stav, M.,Xu, Z.,Barjaktarevic, I.,Han, M.,Labaki, W.,Huang, Y.J,Christenson, S.,O'Neal, W.,Bowler, R.,Sin, D.D,Freeman, C.M,Curtis, J.L, & Hersh, C.P (2023). Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations[J]. American journal of respiratory and critical care medicine, 208(3), 247-255. https://doi.org/10.1164/rccm.
Sanchez-Azofra, A.,Gu, W.,Masso-Silva, J.A,Sanz-Rubio, D.,Marin-Oto, M.,Cubero, P.,Gil, A.V,Moya, E.A,Barnes, L.A,Mesarwi, O.A,Marin, T.,Simonson, T.S,Crotty Alexander, L.E,Marin, J.M, & Malhotra, A. (2023). Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndrome[J]. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 19(8), 1447-1456. https://doi.org/10.5664/jcsm.10600
Sargent, J.D,Halenar, M.,Steinberg, A.W,Ozga, J.,Tang, Z.,Stanton, C.A, & Paulin, L.M (2023). Childhood Cigarette Smoking and Risk of Chronic Obstructive Pulmonary Disease in Older U.S. Adults[J]. American journal of respiratory and critical care medicine, 208(4), 428-434.
https://doi.org/10.1164/rccm.202303-0476OC.
Soriano, J.B,Marín, J.M, & Celli, B.R (2023). Post-bronchodilator spirometry in chronic obstructive pulmonary disease. The Lancet[J]. Respiratory medicine, 11(1), 13-14. https://doi.org/10.1016/S2213-2600(22)00476-3
Sterling, K.L,Pépin, J.L,Linde-Zwirble, W.,Chen, J.,Benjafield, A.V,Cistulli, P.A,Cole, K.V,Emami, H.,Woodford, C.,Armitstead, J.P,Nunez, C.M,Wedzicha, J.A, & Malhotra, A. (2022). Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(2), 197-205. https://doi.org/10.1164/rccm.
Thorstensen, W.M,Rystad Oie, M.,Sue-Chu, M.,Karmhus Steinsvag, S., & Helvik, A.S (2023). Peak nasal inspiratory flow in chronic obstructive pulmonary disease[J]. Rhinology, 61(3), 255-262. https://doi.org/10.4193/Rhin22.316
Webber, E.M,Lin, J.S, & Thomas, R.G (2022). Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force[J]. JAMA, 327(18), 1812-1816. https://doi.org/10.1001/jama.2022.4708
Yang, I.A,Jenkins, C.R, & Salvi, S.S (2022). Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment [J]. The Lancet. Respiratory medicine, 10(5), 497-511. https://doi.org/10.1016/S2213-2600(21)00506-3.
Zhang, B.,Wang, J.,Chen, J.,Ling, Z.,Ren, Y.,Xiong, D., & Guo, L. (2023). Machine learning in chronic obstructive pulmonary disease[J]. Chinese medical journal, 136(5), 536-538.
https://doi.org/10.1097/CM9.
Booth, S.,Hsieh, A.,Mostaco-Guidolin, L.,Koo, H.K,Wu, K.,Aminazadeh, F.,Yang, C.X,Quail, D.,Wei, Y.,Cooper, J.D,Paré, P.D,Hogg, J.C,Vasilescu, D.M, & Hackett, T.L (2023). A Single-Cell Atlas of Small Airway Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study[J]. American journal of respiratory and critical care medicine, 208(4), 472-486. https://doi.org/10.1164/rccm.
Bos, S.,Beeckmans, H.,Vanstapel, A.,Sacreas, A.,Geudens, V.,Willems, L.,Schreurs, I.,Vanaudenaerde, B.M,Schoemans, H., & Vos, R. (2022). Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin?. The Lancet[J]. Respiratory medicine, 10(8), 796-810. https://doi.org/10.1016/S2213-2600(22)00001-7
Cabrera López, C.,Sánchez Santos, A.,Lemes Castellano, A.,Cazorla Rivero, S.,Breña Atienza, J.,González Dávila, E.,Celli, B., & Casanova Macario, C. (2023). Eosinophil Subtypes in Adults with Asthma and Adults with Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 208(2), 155-162. https://doi.org/10.1164/rccm.
Cabrera López, C.,Sánchez Santos, A.,Lemes Castellano, A.,Cazorla Rivero, S.,Breña Atienza, J.,González Dávila, E.,Celli, B., & Casanova Macario, C. (2023). Eosinophil Subtypes in Adults with Asthma and Adults with Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine, 208(2), 155-162. https://doi.org/10.1164/rccm.
Christenson, S.A,Smith, B.M,Bafadhel, M., & Putcha, N. (2022). Chronic obstructive pulmonary disease[J]. Lancet (London, England), 399(10342), 2227-2242. https://doi.org/10.1016/S0140-6736(22)00470-6
Diaz, A.A,Orejas, J.L,Grumley, S.,Nath, H.P,Wang, W.,Dolliver, W.R,Yen, A.,Kligerman, S.J,Jacobs, K.,Manapragada, P.P,Abozeed, M.,Aziz, M.U,Zahid, M.,Ahmed, A.N,Terry, N.L,San José Estépar, R.,Kim, V.,Make, B.J,Han, M.K,Sonavane, S.,Washko, G.R,Cho, M., & San José Estépar, R. (2023). Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease[J]. JAMA, 329(21), 1832-1839. https://doi.org/10.1001/jama.
Duckworth, A.,Gibbons, M.A,Allen, R.J,Almond, H.,Beaumont, R.N,Wood, A.R,Lunnon, K.,Lindsay, M.A,Wain, L.V,Tyrrell, J., & Scotton, C.J (2021). Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study. The Lancet[J]. Respiratory medicine, 9(3), 285-294. https://doi.org/10.1016/S2213-2600(20)30364-7
Ekström, M.,Ferreira, D.,Chang, S.,Louw, S.,Johnson, M.J,Eckert, D.J,Fazekas, B.,Clark, K.J,Agar, M.R,Currow, D.C, & , . (2022). Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial[J]. JAMA, 328(20), 2022-2032. https://doi.org/10.1001/jama.2022.20206
Fahy, J.V, & Locksley, R.M (2023). Immune treatment tackles chronic obstructive pulmonary disease[J]. Nature, 621(7979), 476-477. https://doi.org/10.1038/d41586-023-02517-5
Fawzy, A.,Baker, J.R,Keller, T.L,Feemster, L.C,Donnelly, L.E, & Hansel, N.N (2022). Selected Bibliography of Recent Research in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(11), 1408-1417. https://doi.org/10.1164/rccm.
Feldman, W.B,Avorn, J.,Kesselheim, A.S, & Gagne, J.J (2023). Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers[J]. JAMA internal medicine, 183(7), 685-695. https://doi.org/10.1001/jamainternmed.
Florman, K.EH,Siddharthan, T.,Pollard, S.L,Alupo, P.,Barber, J.A,Chandyo, R.K,Flores-Flores, O.,Kirenga, B.,Mendes, R.G,Miranda, J.J,Mohan, S.,Ricciardi, F.,Rykiel, N.A,Sharma, A.K,Wosu, A.C,Checkley, W.,Hurst, J.R, & , . (2023). Unmet Diagnostic and Therapeutic Opportunities for Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Countries[J]. American journal of respiratory and critical care medicine, 208(4), 442-450. https://doi.org/10.1164/rccm.
Gai, X.,Allwood, B., & Sun, Y. (2023). Post-tuberculosis lung disease and chronic obstructive pulmonary disease[J]. Chinese medical journal, 136(16), 1923-1928. https://doi.org/10.1097/CM9.
Hernández Cordero, A.I,Yang, C.X,Yang, J.,Horvath, S.,Shaipanich, T.,MacIsaac, J.,Lin, D.TS,Kobor, M.S,Guillemi, S.,Harris, M.,Lam, W.,Lam, S.,Montaner, J.,Man, S.FP,Sin, D.D, & Leung, J.M (2022). Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(2), 150-160. https://doi.org/10.1164/rccm.
Kakkera, K.,Atchley, W.T,Kodali, M., & Bartter, T. (2023). Ageing and chronic obstructive pulmonary disease: interrelationships[J]. Current opinion in pulmonary medicine, 29(2), 90-95. https://doi.org/10.1097/MCP.
Kaul, M.,Krow, S.,Tan, A.M, & Singla, S. (2022). Phenotypic Heterogeneity in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 205(1), 118-120. https://doi.org/10.1164/rccm.
Lacasse, Y.,Casaburi, R.,Sliwinski, P.,Chaouat, A.,Fletcher, E.,Haidl, P., & Maltais, F. (2022). Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis[J]. The Lancet. Respiratory medicine, 10(11), 1029-1037. https://doi.org/10.1016/S2213-2600(22)00179-5
Long, H.,Li, S., & Chen, Y. (2023). Digital health in chronic obstructive pulmonary disease[J]. Chronic diseases and translational medicine, 9(2), 90-103. https://doi.org/10.1002/cdt3.68
Madapoosi, S.S,Cruickshank-Quinn, C.,Opron, K.,Erb-Downward, J.R,Begley, L.A,Li, G.,Barjaktarevic, I.,Barr, R.G,Comellas, A.P,Couper, D.J,Cooper, C.B,Freeman, C.M,Han, M.K,Kaner, R.J,Labaki, W.,Martinez, F.J,Ortega, V.E,Peters, S.P,Paine, R.,Woodruff, P.,Curtis, J.L,Huffnagle, G.B,Stringer, K.A,Bowler, R.P,Esther, C.R,Reisdorph, N.,Huang, Y.J, & , . (2022). Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(4), 427-439. https://doi.org/10.1164/rccm.
Malla, G.,Bodduluri, S.,Sthanam, V.,Sharma, G., & Bhatt, S.P (2023). Access to Pulmonary Rehabilitation among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease[J]. Annals of the American Thoracic Society, 20(4), 516-522. https://doi.org/10.1513/AnnalsATS.
Mangione, C.M,Barry, M.J,Nicholson, W.K,Cabana, M.,Caughey, A.B,Chelmow, D.,Coker, T.R,Davis, E.M,Donahue, K.E,Jaén, C.R,Kubik, M.,Li, L.,Ogedegbe, G.,Pbert, L.,Ruiz, J.M,Stevermer, J.,Tseng, C.W, & Wong, J.B (2022). Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement[J]. JAMA, 327(18), 1806-1811. https://doi.org/10.1001/jama.
Moll, M.,Boueiz, A.,Ghosh, A.J,Saferali, A.,Lee, S.,Xu, Z.,Yun, J.H,Hobbs, B.D,Hersh, C.P,Sin, D.D,Tal-Singer, R.,Silverman, E.K,Cho, M.H,Castaldi, P.J, & , . (2022). Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 205(2), 161-170. https://doi.org/10.1164/rccm.
Motahari, A.,Barr, R.G,Han, M.K,Anderson, W.H,Barjaktarevic, I.,Bleecker, E.R,Comellas, A.P,Cooper, C.B,Couper, D.J,Hansel, N.N,Kanner, R.E,Kazerooni, E.A,Lynch, D.A,Martinez, F.J,Newell, J.D,Schroeder, J.D,Smith, B.M,Woodruff, P.G,Hoffman, E.A, & , . (2023). Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 208(6), 67-665. https://doi.org/10.1164/rccm.
Mullin, M.LL, & Milne, S. (2023). Vitamin D deficiency in chronic obstructive pulmonary disease[J]. Current opinion in pulmonary medicine, 29(2), 96-103. ttps://doi.org/10.1097/MCP.0000000000000935
Nam, J.G,Kang, H.R,Lee, S.M,Kim, H.,Rhee, C.,Goo, J.M,Oh, Y.M,Lee, C.H, & Park, C.M (2022). Deep Learning Prediction of Survival in Patients with Chronic Obstructive Pulmonary Disease Using Chest Radiographs[J]. Radiology, 305(1), 199-208. ttps://doi.org/10.1148/radiol.
Otu, A.,Kosmidis, C.,Mathioudakis, A.G,Ibe, C., & Denning, D.W (2023). The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease[J]. Infection, 51(4), 813-829. ttps://doi.org/10.1007/s15010-022-01960-2
Qian, F.,van den Boom, W., & See, K.C (2023). Real-world evidence challenges controlled hypoxemia guidelines for critically ill patients with chronic obstructive pulmonary disease[J]. Intensive care medicine, 49(9), 1133-1135. ttps://doi.org/10.1007/s00134-023-07166-w.
Rabe, K.F,Rennard, S.,Martinez, F.J,Celli, B.R,Singh, D.,Papi, A.,Bafadhel, M.,Heble, J.,Radwan, A.,Soler, X.,Jacob Nara, J.A,Deniz, Y., & Rowe, P.J (2023). Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook[J]. American journal of respiratory and critical care medicine, 208(4), 395-405. https://doi.org/10.1164/rccm.
Raju, S.,Woo, H.,Koehler, K.,Fawzy, A.,Liu, C.,Putcha, N.,Balasubramanian, A.,Peng, R.D,Lin, C.T,Lemoine, C.,Wineke, J.,Berger, R.D,Hansel, N.N, & McCormack, M.C (2023). Indoor Air Pollution and Impaired Cardiac Autonomic Function in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 207(6), 721-730. https://doi.org/10.1164/rccm.
Ritchie, A.I,Baker, J.R,Parekh, T.M,Allinson, J.P,Bhatt, S.P,Donnelly, L.E, & Donaldson, G.C (2021). Update in Chronic Obstructive Pulmonary Disease 2020[J]. American journal of respiratory and critical care medicine, 204(1), 14-22. https://doi.org/10.1164/rccm.
Rojas, J.C,Chokkara, S.,Zhu, M.,Lindenauer, P.K, & Press, V.G (2023). Care Quality for Patients with Chronic Obstructive Pulmonary Disease in the Readmission Penalty Era[J]. American journal of respiratory and critical care medicine, 207(1), 29-37. https://doi.org/10.1164/rccm.
Rustam, S.,Hu, Y.,Mahjour, S.B,Rendeiro, A.F,Ravichandran, H.,Urso, A.,D'Ovidio, F.,Martinez, F.J,Altorki, N.K,Richmond, B.,Polosukhin, V.,Kropski, J.A,Blackwell, T.S,Randell, S.H,Elemento, O., & Shaykhiev, R. (2023). A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 207(9), 1171-1182. https://doi.org/10.1164/rccm.
Rustam, S.,Hu, Y.,Mahjour, S.B,Rendeiro, A.F,Ravichandran, H.,Urso, A.,D'Ovidio, F.,Martinez, F.J,Altorki, N.K,Richmond, B.,Polosukhin, V.,Kropski, J.A,Blackwell, T.S,Randell, S.H,Elemento, O., & Shaykhiev, R. (2023). A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 207(9), 1171-1182. https://doi.org/10.1164/rccm.
Ryu, M.H,Yun, J.H,Morrow, J.D,Saferali, A.,Castaldi, P.,Chase, R.,Stav, M.,Xu, Z.,Barjaktarevic, I.,Han, M.,Labaki, W.,Huang, Y.J,Christenson, S.,O'Neal, W.,Bowler, R.,Sin, D.D,Freeman, C.M,Curtis, J.L, & Hersh, C.P (2023). Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations[J]. American journal of respiratory and critical care medicine, 208(3), 247-255. https://doi.org/10.1164/rccm.
Sanchez-Azofra, A.,Gu, W.,Masso-Silva, J.A,Sanz-Rubio, D.,Marin-Oto, M.,Cubero, P.,Gil, A.V,Moya, E.A,Barnes, L.A,Mesarwi, O.A,Marin, T.,Simonson, T.S,Crotty Alexander, L.E,Marin, J.M, & Malhotra, A. (2023). Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndrome[J]. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 19(8), 1447-1456. https://doi.org/10.5664/jcsm.10600
Sargent, J.D,Halenar, M.,Steinberg, A.W,Ozga, J.,Tang, Z.,Stanton, C.A, & Paulin, L.M (2023). Childhood Cigarette Smoking and Risk of Chronic Obstructive Pulmonary Disease in Older U.S. Adults[J]. American journal of respiratory and critical care medicine, 208(4), 428-434.
https://doi.org/10.1164/rccm.202303-0476OC.
Soriano, J.B,Marín, J.M, & Celli, B.R (2023). Post-bronchodilator spirometry in chronic obstructive pulmonary disease. The Lancet[J]. Respiratory medicine, 11(1), 13-14. https://doi.org/10.1016/S2213-2600(22)00476-3
Sterling, K.L,Pépin, J.L,Linde-Zwirble, W.,Chen, J.,Benjafield, A.V,Cistulli, P.A,Cole, K.V,Emami, H.,Woodford, C.,Armitstead, J.P,Nunez, C.M,Wedzicha, J.A, & Malhotra, A. (2022). Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease[J]. American journal of respiratory and critical care medicine, 206(2), 197-205. https://doi.org/10.1164/rccm.
Thorstensen, W.M,Rystad Oie, M.,Sue-Chu, M.,Karmhus Steinsvag, S., & Helvik, A.S (2023). Peak nasal inspiratory flow in chronic obstructive pulmonary disease[J]. Rhinology, 61(3), 255-262. https://doi.org/10.4193/Rhin22.316
Webber, E.M,Lin, J.S, & Thomas, R.G (2022). Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force[J]. JAMA, 327(18), 1812-1816. https://doi.org/10.1001/jama.2022.4708
Yang, I.A,Jenkins, C.R, & Salvi, S.S (2022). Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment [J]. The Lancet. Respiratory medicine, 10(5), 497-511. https://doi.org/10.1016/S2213-2600(21)00506-3.
Zhang, B.,Wang, J.,Chen, J.,Ling, Z.,Ren, Y.,Xiong, D., & Guo, L. (2023). Machine learning in chronic obstructive pulmonary disease[J]. Chinese medical journal, 136(5), 536-538.
https://doi.org/10.1097/CM9.
Published
2024/10/03
Section
Original paper
Copyright (c) 2024 Yijia Sun
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.